LEUPROLIDE ACETATE

LEUPROLIDE ACETATE was reported 78177 times

LEUPROLIDE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTERCEPTED PRODUCT PREPARATION ERROR 9496 0.7708
1 INJECTION SITE ABSCESS STERILE 62 0.5487
2 BULBOSPINAL MUSCULAR ATROPHY CONGENITAL 22 0.5116
3 SYRINGE ISSUE 7914 0.4517
4 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 448 0.4316
5 BLOOD LUTEINISING HORMONE ABNORMAL 20 0.3922
6 ABSCESS STERILE 56 0.3784
7 BLOOD TESTOSTERONE ABNORMAL 385 0.3478
8 INTERCEPTED MEDICATION ERROR 1131 0.2439
9 PROSTATE CANCER METASTATIC 690 0.2063
10 BLOOD TESTOSTERONE INCREASED 430 0.1998
11 PROSTATIC SPECIFIC ANTIGEN INCREASED 2440 0.1769
12 PRODUCT PHYSICAL CONSISTENCY ISSUE 957 0.1727
13 RADIATION PROCTITIS 32 0.1720
14 ENDOMETRIOSIS 772 0.1617
15 LAPAROSCOPY 41 0.1559
16 DEVICE LEAKAGE 6393 0.1473
17 CHILD ABUSE 38 0.1467
18 HORMONE-REFRACTORY PROSTATE CANCER 174 0.1465
19 PRODUCT RECONSTITUTION QUALITY ISSUE 131 0.1464
20 PROSTATE CANCER RECURRENT 90 0.1461
21 CYSTITIS RADIATION 27 0.1399
22 EPIDURAL LIPOMATOSIS 47 0.1366
23 VICTIM OF CHILD ABUSE 34 0.1355
24 HOT FLUSH 9603 0.1273
25 PALLIATIVE CARE 191 0.1247
26 PROSTATIC SPECIFIC ANTIGEN DECREASED 47 0.1243
27 PRODUCT ADMINISTERED BY WRONG PERSON 44 0.1152
28 BLOOD LUTEINISING HORMONE INCREASED 28 0.1138
29 OESTRADIOL INCREASED 31 0.1030
30 INJECTION SITE GRANULOMA 23 0.0970
31 TERMINAL STATE 645 0.0963
32 POST PROCEDURAL DIARRHOEA 49 0.0963
33 TESTICULAR ATROPHY 79 0.0906
34 METASTASES TO BLADDER 23 0.0807
35 ADNEXA UTERI PAIN 103 0.0805
36 DEVICE CONNECTION ISSUE 167 0.0791
37 INJECTION SITE ABSCESS 188 0.0755
38 PRODUCT RECONSTITUTION ISSUE 23 0.0730
39 MENSTRUATION NORMAL 24 0.0723
40 DEVICE OCCLUSION 1017 0.0722
41 LIPID METABOLISM DISORDER 27 0.0703
42 EUTHANASIA 22 0.0694
43 BONE CANCER METASTATIC 36 0.0681
44 RADIATION INJURY 66 0.0620
45 PRODUCT LEAKAGE 333 0.0593
46 URETHRAL OBSTRUCTION 24 0.0593
47 MALE SEXUAL DYSFUNCTION 35 0.0584
48 PROSTATECTOMY 33 0.0575
49 ENDOMETRIAL ABLATION 20 0.0560
50 OOPHORECTOMY 49 0.0549
51 OCCUPATIONAL EXPOSURE TO PRODUCT 338 0.0525
52 MALIGNANT TRANSFORMATION 23 0.0512
53 METASTASES TO BONE 834 0.0508
54 ADENOMYOSIS 30 0.0508
55 METASTASES TO PELVIS 31 0.0491
56 TRANSURETHRAL PROSTATECTOMY 23 0.0460
57 PELVIC PAIN 825 0.0454
58 METASTASES TO SPINE 152 0.0452
59 INTERCEPTED PRODUCT ADMINISTRATION ERROR 346 0.0451
60 UTERINE LEIOMYOMA 328 0.0448
61 MENSTRUAL DISORDER 366 0.0441
62 URETHRAL STENOSIS 28 0.0409
63 PELVIC MASS 33 0.0409
64 BLOOD OESTROGEN INCREASED 23 0.0390
65 PENILE SIZE REDUCED 36 0.0379
66 DRUG ADMINISTERED IN WRONG DEVICE 37 0.0378
67 INJECTION SITE MASS 1366 0.0369
68 PRECOCIOUS PUBERTY 21 0.0368
69 UTERINE PAIN 37 0.0360
70 OVARIAN CYST RUPTURED 46 0.0358
71 VULVOVAGINAL DRYNESS 115 0.0355
72 CANCER PAIN 90 0.0352
73 URINARY TRACT OBSTRUCTION 79 0.0333
74 UTERINE ENLARGEMENT 26 0.0327
75 WRONG DEVICE USED 21 0.0320
76 BREAST ENLARGEMENT 104 0.0317
77 PRODUCT ADMINISTRATION ERROR 619 0.0306
78 HYSTERECTOMY 265 0.0306
79 BONE CANCER 132 0.0303
80 MENORRHAGIA 591 0.0301
81 URINARY BLADDER HAEMORRHAGE 63 0.0299
82 BLOOD UREA ABNORMAL 28 0.0298
83 FAT TISSUE INCREASED 42 0.0289
84 HAEMORRHAGE URINARY TRACT 72 0.0283
85 NOCTURIA 339 0.0279
86 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5625 0.0277
87 ADHESION 41 0.0272
88 MOOD SWINGS 853 0.0267
89 OVARIAN DISORDER 25 0.0266
90 INJECTION SITE ULCER 25 0.0265
91 BLADDER NEOPLASM 44 0.0257
92 RADIOTHERAPY 49 0.0256
93 NIGHT SWEATS 813 0.0252
94 ONCOLOGIC COMPLICATION 23 0.0238
95 NEEDLE ISSUE 690 0.0237
96 CALCULUS BLADDER 32 0.0234
97 PRODUCT PREPARATION ERROR 475 0.0231
98 INTERCEPTED PRODUCT SELECTION ERROR 30 0.0230
99 PROSTATE CANCER 1849 0.0230
100 TESTICULAR DISORDER 23 0.0228
101 METASTASES TO LYMPH NODES 154 0.0228
102 BLOOD ELECTROLYTES ABNORMAL 28 0.0226
103 METASTASIS 161 0.0225
104 OVARIAN HYPERSTIMULATION SYNDROME 51 0.0219
105 VAGINAL HAEMORRHAGE 933 0.0215
106 METRORRHAGIA 354 0.0207
107 BLADDER CATHETERISATION 20 0.0206
108 URETERIC OBSTRUCTION 28 0.0205
109 WAIST CIRCUMFERENCE INCREASED 21 0.0203
110 INJECTION SITE INFECTION 66 0.0201
111 METASTATIC NEOPLASM 86 0.0199
112 MUSCLE ATROPHY 252 0.0199
113 UTERINE SPASM 36 0.0197
114 JUVENILE IDIOPATHIC ARTHRITIS 48 0.0196
115 OVARIAN CYST 195 0.0195
116 INTENTIONAL PRODUCT USE ISSUE 1675 0.0191
117 LOSS OF LIBIDO 171 0.0190
118 NIPPLE PAIN 38 0.0186
119 TESTICULAR PAIN 59 0.0186
120 INJECTION SITE NECROSIS 37 0.0181
121 INTERCEPTED PRODUCT PRESCRIBING ERROR 24 0.0181
122 MENOPAUSAL SYMPTOMS 42 0.0180
123 INJECTION SITE NODULE 194 0.0176
124 BREAST TENDERNESS 130 0.0172
125 INJECTION SITE INDURATION 218 0.0168
126 INJECTION SITE DISCOMFORT 175 0.0166
127 BONE LESION 60 0.0166
128 INFERTILITY 25 0.0166
129 INTERCEPTED PRODUCT STORAGE ERROR 59 0.0165
130 PRODUCT PREPARATION ISSUE 108 0.0164
131 INJECTION SITE PAIN 4899 0.0160
132 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 272 0.0158
133 UTERINE HAEMORRHAGE 67 0.0157
134 INTERCEPTED PRODUCT DISPENSING ERROR 26 0.0157
135 BREAST SWELLING 42 0.0156
136 DYSMENORRHOEA 207 0.0156
137 METASTASES TO LUNG 177 0.0153
138 DYSPAREUNIA 70 0.0152
139 INJECTION SITE OEDEMA 25 0.0145
140 DYSURIA 534 0.0145
141 INTENTIONAL DOSE OMISSION 410 0.0144
142 URINE FLOW DECREASED 34 0.0142
143 PRODUCT COLOUR ISSUE 73 0.0142
144 HORMONE LEVEL ABNORMAL 67 0.0137
145 LIBIDO INCREASED 27 0.0133
146 OLIGOMENORRHOEA 28 0.0128
147 HYDRONEPHROSIS 96 0.0128
148 MENOPAUSE 33 0.0128
149 PROSTATOMEGALY 50 0.0127
150 BLOOD TESTOSTERONE DECREASED 86 0.0126
151 PROSTATE CANCER STAGE IV 44 0.0124
152 INGUINAL HERNIA 75 0.0123
153 MOOD ALTERED 334 0.0122
154 IMPATIENCE 23 0.0122
155 POLLAKIURIA 486 0.0116
156 GROIN PAIN 100 0.0114
157 INJECTION SITE DISCHARGE 61 0.0113
158 URINARY RETENTION 378 0.0113
159 AFFECT LABILITY 107 0.0111
160 BONE PAIN 651 0.0111
161 BLADDER PAIN 35 0.0110
162 HAEMATURIA 366 0.0107
163 GYNAECOMASTIA 330 0.0107
164 EXERCISE TOLERANCE DECREASED 59 0.0102
165 INJECTION SITE INFLAMMATION 51 0.0102
166 EMBOLIC STROKE 36 0.0102
167 METASTASES TO LIVER 179 0.0102
168 DEATH 8735 0.0101
169 PRODUCT TEMPERATURE EXCURSION ISSUE 51 0.0099
170 HYPOMENORRHOEA 27 0.0098
171 BREAST PAIN 105 0.0098
172 MICTURITION URGENCY 112 0.0098
173 HAIR GROWTH ABNORMAL 66 0.0095
174 HYPERTONIC BLADDER 27 0.0093
175 PROCTALGIA 60 0.0093
176 URINARY TRACT DISORDER 42 0.0093
177 HIP FRACTURE 296 0.0092
178 HUMERUS FRACTURE 44 0.0091
179 VAGINAL DISCHARGE 92 0.0091
180 INJURY ASSOCIATED WITH DEVICE 185 0.0091
181 ERECTILE DYSFUNCTION 232 0.0090
182 MUSCLE FATIGUE 38 0.0090
183 BLOOD URINE PRESENT 170 0.0089
184 VULVOVAGINAL PAIN 43 0.0089
185 DRUG DISPENSING ERROR 132 0.0086
186 AMENORRHOEA 151 0.0086
187 COMPRESSION FRACTURE 46 0.0086
188 CACHEXIA 44 0.0085
189 INCONTINENCE 89 0.0084
190 INJECTION SITE HYPERSENSITIVITY 26 0.0083
191 ABDOMINAL ADHESIONS 26 0.0082
192 SPINAL CORD COMPRESSION 32 0.0082
193 INSURANCE ISSUE 125 0.0082
194 APPENDICECTOMY 29 0.0081
195 POLYMENORRHOEA 28 0.0081
196 WEIGHT INCREASED 1802 0.0080
197 FEMORAL NECK FRACTURE 41 0.0080
198 LUNG CANCER METASTATIC 23 0.0080
199 PARAPLEGIA 23 0.0080
200 INJECTION SITE HAEMORRHAGE 635 0.0079
201 RESPIRATORY DEPRESSION 97 0.0079
202 URINARY INCONTINENCE 234 0.0079
203 BLADDER DISORDER 77 0.0077
204 PATHOLOGICAL FRACTURE 39 0.0077
205 CHEMOTHERAPY 29 0.0077
206 EMOTIONAL DISORDER 234 0.0076
207 PROSTATITIS 23 0.0076
208 CERVICAL VERTEBRAL FRACTURE 26 0.0075
209 HYPERHIDROSIS 944 0.0073
210 RIB FRACTURE 149 0.0072
211 MICTURITION DISORDER 25 0.0072
212 RECTAL CANCER 22 0.0072
213 SPINAL COMPRESSION FRACTURE 59 0.0071
214 WALKING AID USER 47 0.0071
215 DEVICE DEFECTIVE 123 0.0071
216 MOBILITY DECREASED 507 0.0070
217 MUSCULOSKELETAL CHEST PAIN 108 0.0070
218 EXPIRED DRUG ADMINISTERED 34 0.0069
219 MENSTRUATION IRREGULAR 183 0.0068
220 CLAVICLE FRACTURE 26 0.0068
221 PROCEDURAL COMPLICATION 51 0.0066
222 DEMENTIA 185 0.0066
223 FATIGUE 5153 0.0066
224 SECOND PRIMARY MALIGNANCY 55 0.0066
225 POOR QUALITY SLEEP 142 0.0066
226 CRYING 239 0.0066
227 TEARFULNESS 28 0.0065
228 ASTHENIA 2439 0.0065
229 BONE DISORDER 117 0.0064
230 GRANULOMA 22 0.0063
231 LIQUID PRODUCT PHYSICAL ISSUE 46 0.0063
232 SPINAL FRACTURE 126 0.0063
233 CYST 78 0.0063
234 GENERAL PHYSICAL HEALTH DETERIORATION 726 0.0063
235 AORTIC ANEURYSM 47 0.0062
236 BEDRIDDEN 81 0.0062
237 BACK PAIN 1429 0.0061
238 MUSCULAR WEAKNESS 696 0.0061
239 LUMBAR VERTEBRAL FRACTURE 28 0.0061
240 DIZZINESS POSTURAL 59 0.0061
241 DEPRESSED MOOD 321 0.0061
242 FALL 2011 0.0060
243 UMBILICAL HERNIA 28 0.0060
244 MALIGNANT NEOPLASM PROGRESSION 606 0.0059
245 PULMONARY MASS 88 0.0059
246 INCREASED APPETITE 112 0.0059
247 FEELING COLD 163 0.0058
248 TENDERNESS 61 0.0058
249 UROSEPSIS 54 0.0058
250 LOCALISED OEDEMA 27 0.0058
251 FAILURE TO THRIVE 30 0.0058
252 HOSPICE CARE 57 0.0058
253 ABDOMINAL HERNIA 26 0.0057
254 PRODUCT PRESCRIBING ERROR 135 0.0057
255 PHLEBITIS 29 0.0057
256 BRAIN NEOPLASM 52 0.0057
257 ANKLE FRACTURE 87 0.0056
258 LUNG NEOPLASM 24 0.0056
259 PROSTATIC DISORDER 31 0.0056
260 AMNESIA 364 0.0056
261 FOETAL DEATH 29 0.0056
262 DYSPNOEA EXERTIONAL 210 0.0056
263 AUTOIMMUNE THYROIDITIS 21 0.0055
264 PRODUCT SOLUBILITY ABNORMAL 28 0.0055
265 ABDOMINAL PAIN LOWER 140 0.0055
266 SPINAL OSTEOARTHRITIS 48 0.0055
267 PNEUMONIA ASPIRATION 136 0.0054
268 REHABILITATION THERAPY 21 0.0054
269 GAIT INABILITY 178 0.0053
270 IMMOBILE 23 0.0053
271 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 945 0.0052
272 MIGRAINE 500 0.0052
273 COLON CANCER 78 0.0052
274 NEOPLASM 60 0.0052
275 CORONARY ARTERY BYPASS 30 0.0052
276 LYMPHOEDEMA 36 0.0052
277 METASTASES TO CENTRAL NERVOUS SYSTEM 67 0.0052
278 POLYP 34 0.0052
279 CORONARY ARTERY STENOSIS 26 0.0052
280 INJECTION SITE HAEMATOMA 75 0.0052
281 CARDIAC FAILURE CHRONIC 22 0.0052
282 PURULENT DISCHARGE 22 0.0051
283 APATHY 75 0.0051
284 HAEMOGLOBIN ABNORMAL 33 0.0051
285 DYSLIPIDAEMIA 26 0.0051
286 FEELING OF BODY TEMPERATURE CHANGE 30 0.0051
287 LYMPHADENOPATHY 181 0.0051
288 OSTEOPOROSIS 210 0.0051
289 ABDOMINAL PAIN 1183 0.0051
290 SKIN ABRASION 24 0.0051
291 IRRITABILITY 305 0.0051
292 SKIN LACERATION 55 0.0051
293 BLOOD IRON DECREASED 60 0.0051
294 OSTEONECROSIS OF JAW 125 0.0050
295 ANEURYSM 25 0.0050
296 CEREBRAL ATROPHY 20 0.0050
297 QUALITY OF LIFE DECREASED 67 0.0050
298 ARTERIAL OCCLUSIVE DISEASE 39 0.0050
299 WRONG DRUG ADMINISTERED 44 0.0049
300 COLD SWEAT 87 0.0049
301 FEELING OF DESPAIR 23 0.0049
302 INTERVERTEBRAL DISC DISORDER 21 0.0049
303 RENAL CYST 39 0.0049
304 VAGINAL INFECTION 23 0.0049
305 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 165 0.0049
306 POLYURIA 40 0.0049
307 WRONG PRODUCT ADMINISTERED 33 0.0049
308 HYPERAESTHESIA 40 0.0049
309 SPINAL PAIN 57 0.0049
310 DIABETES MELLITUS 368 0.0048
311 NORMAL NEWBORN 26 0.0048
312 ANAL INCONTINENCE 43 0.0048
313 ARTHRALGIA 1982 0.0048
314 BREAST MASS 32 0.0048
315 PELVIC FRACTURE 37 0.0047
316 REFUSAL OF TREATMENT BY PATIENT 31 0.0047
317 SURGERY 276 0.0047
318 ABDOMINAL DISTENSION 490 0.0047
319 LETHARGY 268 0.0047
320 CYSTITIS 148 0.0046
321 PALLOR 126 0.0046
322 INSOMNIA 1227 0.0046
323 FLANK PAIN 43 0.0046
324 DEPRESSION 1036 0.0045
325 PRODUCT QUALITY ISSUE 613 0.0045
326 SUDDEN DEATH 47 0.0044
327 URINE ODOUR ABNORMAL 26 0.0044
328 ANGER 149 0.0044
329 DECUBITUS ULCER 35 0.0043
330 ACUTE PULMONARY OEDEMA 24 0.0043
331 SCIATICA 68 0.0043
332 ABSCESS 68 0.0043
333 DECREASED APPETITE 989 0.0043
334 LIGAMENT SPRAIN 42 0.0042
335 RENAL PAIN 45 0.0042
336 WEIGHT DECREASED 1183 0.0042
337 HAEMORRHAGE 443 0.0042
338 GLUCOSE TOLERANCE IMPAIRED 25 0.0042
339 INTERVERTEBRAL DISC DEGENERATION 39 0.0042
340 MUSCLE DISORDER 34 0.0042
341 OEDEMA PERIPHERAL 508 0.0042
342 POST PROCEDURAL COMPLICATION 80 0.0042
343 INJECTION SITE EXTRAVASATION 51 0.0041
344 CONCUSSION 32 0.0041
345 SKIN WARM 24 0.0041
346 MIDDLE INSOMNIA 77 0.0041
347 PAIN IN EXTREMITY 1214 0.0041
348 WEIGHT LOSS POOR 21 0.0041
349 ACUTE CORONARY SYNDROME 34 0.0041
350 VITAMIN D DEFICIENCY 40 0.0041
351 BREAST CANCER METASTATIC 44 0.0041
352 CEREBRAL INFARCTION 100 0.0041
353 ANAEMIA 769 0.0040
354 OSTEOPENIA 61 0.0040
355 LOWER LIMB FRACTURE 77 0.0040
356 HYPOPHAGIA 102 0.0040
357 DYSSTASIA 116 0.0040
358 INJECTION SITE SWELLING 303 0.0040
359 SLEEP DISORDER 278 0.0039
360 INJECTION SITE WARMTH 81 0.0039
361 CORONARY ARTERY OCCLUSION 54 0.0039
362 RECTAL HAEMORRHAGE 169 0.0039
363 ONYCHOCLASIS 27 0.0039
364 TRANSIENT ISCHAEMIC ATTACK 132 0.0039
365 PRODUCT DISPENSING ERROR 85 0.0039
366 HEAVY MENSTRUAL BLEEDING 35 0.0039
367 MALIGNANT MELANOMA 52 0.0039
368 EXPIRED PRODUCT ADMINISTERED 129 0.0039
369 HYPERSOMNIA 111 0.0039
370 SENSORY DISTURBANCE 62 0.0039
371 CARDIAC PACEMAKER INSERTION 23 0.0039
372 GASTROINTESTINAL CARCINOMA 35 0.0039
373 CARDIAC VALVE DISEASE 22 0.0038
374 LUNG NEOPLASM MALIGNANT 158 0.0038
375 URINARY TRACT INFECTION 654 0.0038
376 GAIT DISTURBANCE 733 0.0038
377 UPPER LIMB FRACTURE 76 0.0038
378 HYPOAESTHESIA 569 0.0038
379 INJECTION SITE VESICLES 23 0.0038
380 MYALGIA 646 0.0038
381 PERIPHERAL COLDNESS 52 0.0038
382 MUSCULOSKELETAL PAIN 198 0.0038
383 MEMORY IMPAIRMENT 518 0.0038
384 EMPHYSEMA 38 0.0038
385 OBESITY 60 0.0038
386 INTERMENSTRUAL BLEEDING 21 0.0038
387 INTERVERTEBRAL DISC PROTRUSION 82 0.0037
388 NEOPLASM MALIGNANT 250 0.0037
389 MUSCLE SPASMS 687 0.0037
390 HYPERTRANSAMINASAEMIA 26 0.0037
391 VISUAL FIELD DEFECT 27 0.0037
392 DECREASED ACTIVITY 40 0.0037
393 HIP SURGERY 20 0.0037
394 CHOLECYSTECTOMY 42 0.0037
395 POLYNEUROPATHY 44 0.0037
396 DIABETES MELLITUS INADEQUATE CONTROL 65 0.0037
397 HYDROCEPHALUS 20 0.0037
398 FEMUR FRACTURE 113 0.0036
399 FRACTURE 69 0.0036
400 APPENDICITIS 34 0.0036
401 HEPATOTOXICITY 81 0.0036
402 HYPOTONIA 36 0.0036
403 INTRACRANIAL PRESSURE INCREASED 20 0.0036
404 DIZZINESS 1790 0.0036
405 OSTEOARTHRITIS 152 0.0036
406 SEXUAL DYSFUNCTION 42 0.0036
407 INCORRECT PRODUCT STORAGE 47 0.0036
408 BALANCE DISORDER 309 0.0036
409 HEAD INJURY 113 0.0036
410 KIDNEY INFECTION 70 0.0036
411 VENTRICULAR EXTRASYSTOLES 37 0.0036
412 ENERGY INCREASED 21 0.0036
413 TASTE DISORDER 72 0.0035
414 TROPONIN INCREASED 27 0.0035
415 FOOT FRACTURE 67 0.0035
416 SKIN CANCER 76 0.0035
417 INFARCTION 24 0.0035
418 FEELING HOT 215 0.0035
419 MASS 49 0.0035
420 HYPERTENSIVE CRISIS 39 0.0035
421 MALNUTRITION 39 0.0035
422 ARTERIOSCLEROSIS CORONARY ARTERY 23 0.0035
423 APPETITE DISORDER 23 0.0035
424 MUSCLE STRAIN 30 0.0035
425 JOINT INJURY 74 0.0035
426 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 166 0.0035
427 TOOTH FRACTURE 38 0.0034
428 BRAIN FOG 54 0.0034
429 POST PROCEDURAL INFECTION 28 0.0034
430 DISEASE PROGRESSION 407 0.0034
431 LYMPHOMA 53 0.0034
432 NEOPLASM PROGRESSION 119 0.0034
433 ABASIA 84 0.0034
434 SYNCOPE 340 0.0034
435 DECREASED INTEREST 20 0.0034
436 LIMB INJURY 92 0.0034
437 ACTIVITIES OF DAILY LIVING IMPAIRED 67 0.0034
438 UNDERDOSE 247 0.0034
439 ARTHROPOD BITE 25 0.0034
440 FIBROMYALGIA 82 0.0034
441 INCREASED TENDENCY TO BRUISE 31 0.0034
442 PERIPHERAL SWELLING 516 0.0033
443 CONSTIPATION 729 0.0033
444 PNEUMOTHORAX 53 0.0033
445 COGNITIVE DISORDER 156 0.0033
446 INCORRECT ROUTE OF DRUG ADMINISTRATION 119 0.0033
447 HYPOCALCAEMIA 63 0.0033
448 MUSCULOSKELETAL DISCOMFORT 57 0.0033
449 CARDIAC DISORDER 309 0.0033
450 PLEURAL EFFUSION 199 0.0033
451 CARDIAC FAILURE 262 0.0033
452 THERAPY INTERRUPTED 232 0.0032
453 NERVE INJURY 36 0.0032
454 SENSORY LOSS 26 0.0032
455 NODULE 42 0.0032
456 LOCAL SWELLING 56 0.0032
457 PULMONARY EMBOLISM 305 0.0032
458 ATELECTASIS 31 0.0032
459 ALOPECIA 630 0.0032
460 HERNIA 62 0.0032
461 PAIN 1951 0.0032
462 THROMBOSIS 255 0.0032
463 SPINAL DISORDER 30 0.0032
464 HEPATIC STEATOSIS 59 0.0032
465 PRODUCT AVAILABILITY ISSUE 72 0.0032
466 FORMICATION 22 0.0032
467 NEPHROLITHIASIS 145 0.0032
468 TRANSFUSION 33 0.0031
469 MAJOR DEPRESSION 23 0.0031
470 ATRIOVENTRICULAR BLOCK COMPLETE 21 0.0031
471 IMPAIRED WORK ABILITY 67 0.0031
472 PRESYNCOPE 76 0.0031
473 HAEMOGLOBIN DECREASED 320 0.0031
474 BLOOD CALCIUM DECREASED 35 0.0031
475 CORONARY ARTERY DISEASE 94 0.0031
476 PULMONARY OEDEMA 139 0.0031
477 HEADACHE 1946 0.0031
478 GENERAL PHYSICAL CONDITION ABNORMAL 21 0.0031
479 BONE DENSITY DECREASED 97 0.0031
480 FRUSTRATION TOLERANCE DECREASED 25 0.0031
481 LEUKAEMIA 29 0.0031
482 DELIRIUM 106 0.0031
483 HEART RATE IRREGULAR 69 0.0031
484 CEREBROVASCULAR ACCIDENT 516 0.0030
485 BACK INJURY 33 0.0030
486 NERVE COMPRESSION 28 0.0030
487 UNEVALUABLE EVENT 229 0.0030
488 ANGINA PECTORIS 86 0.0030
489 GASTROINTESTINAL PAIN 33 0.0030
490 PNEUMONIA 970 0.0030
491 NECK PAIN 167 0.0030
492 CHILLS 349 0.0030
493 RESTLESS LEGS SYNDROME 54 0.0030
494 CONFUSIONAL STATE 478 0.0030
495 ARRHYTHMIA 140 0.0030
496 INTERSTITIAL LUNG DISEASE 143 0.0030
497 HEMIPARESIS 50 0.0029
498 HYPERTENSION 625 0.0029
499 DERMATITIS ALLERGIC 37 0.0029
500 VITAMIN D DECREASED 25 0.0029
501 NEURALGIA 71 0.0029
502 PARAESTHESIA 459 0.0029
503 ECCHYMOSIS 20 0.0029
504 PERSONALITY CHANGE 27 0.0029
505 ADVERSE DRUG REACTION 261 0.0029
506 RED BLOOD CELL COUNT DECREASED 83 0.0029
507 EMBOLISM 24 0.0029
508 FAECES SOFT 21 0.0029
509 LARGE INTESTINE POLYP 20 0.0029
510 APHASIA 87 0.0029
511 CHROMATURIA 65 0.0029
512 RESPIRATORY DISORDER 86 0.0029
513 BOWEL MOVEMENT IRREGULARITY 22 0.0029
514 LACERATION 27 0.0029
515 BLOOD DISORDER 23 0.0029
516 ARTERIOSCLEROSIS 27 0.0029
517 JOINT STIFFNESS 75 0.0029
518 AGEUSIA 71 0.0028
519 WRIST FRACTURE 34 0.0028
520 GENERALISED OEDEMA 35 0.0028
521 PRODUCT PHYSICAL ISSUE 57 0.0028
522 PAIN IN JAW 80 0.0028
523 ASCITES 83 0.0028
524 INJECTION SITE ERYTHEMA 350 0.0028
525 ABORTION SPONTANEOUS 113 0.0028
526 HAEMORRHOIDS 55 0.0028
527 HAEMATOCHEZIA 155 0.0028
528 INJECTION SITE DISCOLOURATION 35 0.0028
529 AFFECTIVE DISORDER 22 0.0028
530 SUBDURAL HAEMATOMA 40 0.0028
531 GOUT 50 0.0028
532 HEPATIC FUNCTION ABNORMAL 103 0.0028
533 OFF LABEL USE 2416 0.0028
534 COVID-19 483 0.0028
535 ATRIAL FIBRILLATION 268 0.0027
536 PULMONARY THROMBOSIS 30 0.0027
537 MUSCULOSKELETAL STIFFNESS 241 0.0027
538 LIMB DISCOMFORT 85 0.0027
539 CHOLELITHIASIS 90 0.0027
540 HIP ARTHROPLASTY 42 0.0027
541 BLOOD ALKALINE PHOSPHATASE INCREASED 68 0.0027
542 STENT PLACEMENT 22 0.0027
543 PARALYSIS 39 0.0027
544 ELECTROCARDIOGRAM QT PROLONGED 98 0.0027
545 MYOCARDIAL ISCHAEMIA 31 0.0027
546 MEDICATION ERROR 151 0.0027
547 TEMPERATURE INTOLERANCE 28 0.0027
548 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 193 0.0027
549 LOSS OF CONSCIOUSNESS 346 0.0027
550 HERPES ZOSTER 154 0.0027
551 ACCIDENT 32 0.0027
552 INJECTION SITE IRRITATION 34 0.0027
553 CONTUSION 257 0.0027
554 MYOCARDIAL INFARCTION 464 0.0027
555 RENAL TUBULAR NECROSIS 26 0.0026
556 IMPAIRED QUALITY OF LIFE 38 0.0026
557 DEAFNESS 69 0.0026
558 BURSITIS 32 0.0026
559 PRODUCT PACKAGING ISSUE 25 0.0026
560 LIVE BIRTH 22 0.0026
561 INTESTINAL OBSTRUCTION 99 0.0026
562 HAEMATOMA 68 0.0026
563 BLOOD PRESSURE ABNORMAL 52 0.0026
564 BLOOD PRESSURE INCREASED 399 0.0026
565 BLOOD PRESSURE DECREASED 173 0.0026
566 SINUS CONGESTION 35 0.0026
567 ORTHOSTATIC HYPOTENSION 45 0.0026
568 HOSPITALISATION 397 0.0026
569 CHEST PAIN 478 0.0026
570 SHOCK HAEMORRHAGIC 21 0.0026
571 NEUROPATHY PERIPHERAL 245 0.0026
572 HAEMATEMESIS 65 0.0026
573 LOCALISED INFECTION 62 0.0026
574 SPLENOMEGALY 30 0.0026
575 ANXIETY 727 0.0026
576 ACUTE MYOCARDIAL INFARCTION 75 0.0025
577 TOOTHACHE 46 0.0025
578 OSTEOMYELITIS 46 0.0025
579 MALAISE 1112 0.0025
580 SUICIDAL IDEATION 232 0.0025
581 INITIAL INSOMNIA 26 0.0025
582 BONE LOSS 38 0.0025
583 DISTURBANCE IN ATTENTION 136 0.0025
584 ISCHAEMIC STROKE 45 0.0025
585 THERAPY CESSATION 129 0.0025
586 DEVICE BREAKAGE 102 0.0025
587 TOOTH EXTRACTION 31 0.0025
588 HYPERCHOLESTEROLAEMIA 24 0.0025
589 CATARACT 148 0.0025
590 CARDIAC FAILURE CONGESTIVE 199 0.0025
591 WOUND INFECTION 27 0.0025
592 FEEDING DISORDER 50 0.0025
593 JOINT DISLOCATION 26 0.0025
594 COVID-19 PNEUMONIA 29 0.0025
595 SCAB 28 0.0025
596 ASPHYXIA 20 0.0024
597 HUNGER 34 0.0024
598 FLUID RETENTION 124 0.0024
599 DEHYDRATION 325 0.0024
600 FEELING ABNORMAL 583 0.0024
601 VERTIGO 148 0.0024
602 HAIR DISORDER 20 0.0024
603 HAEMATOCRIT DECREASED 48 0.0024
604 HEMIPLEGIA 20 0.0024
605 INJECTION SITE REACTION 165 0.0024
606 EXTRA DOSE ADMINISTERED 97 0.0024
607 BLOOD CALCIUM INCREASED 21 0.0024
608 MENTAL IMPAIRMENT 58 0.0024
609 NERVOUSNESS 125 0.0024
610 GLAUCOMA 46 0.0024
611 BLOOD SODIUM DECREASED 45 0.0024
612 BLOOD GLUCOSE ABNORMAL 44 0.0024
613 CELLULITIS 120 0.0024
614 DEVICE ISSUE 212 0.0024
615 SLUGGISHNESS 24 0.0024
616 ACNE 178 0.0023
617 FACIAL PARALYSIS 20 0.0023
618 INCORRECT DOSE ADMINISTERED BY DEVICE 61 0.0023
619 CARDIAC OPERATION 20 0.0023
620 SEPSIS 259 0.0023
621 INJECTION SITE BRUISING 185 0.0023
622 CEREBRAL HAEMORRHAGE 83 0.0023
623 CARDIAC MURMUR 20 0.0023
624 VISION BLURRED 317 0.0023
625 HEPATIC CIRRHOSIS 43 0.0023
626 NAIL DISORDER 20 0.0023
627 SKIN ULCER 59 0.0023
628 INCORRECT DOSE ADMINISTERED 520 0.0023
629 CARDIOMEGALY 28 0.0023
630 INTERNAL HAEMORRHAGE 26 0.0023
631 DISSEMINATED INTRAVASCULAR COAGULATION 32 0.0023
632 ROAD TRAFFIC ACCIDENT 95 0.0023
633 RASH PRURITIC 123 0.0023
634 EXPOSURE DURING PREGNANCY 141 0.0023
635 EAR PAIN 44 0.0023
636 BLOOD CHOLESTEROL INCREASED 105 0.0023
637 HIATUS HERNIA 29 0.0022
638 ELECTROLYTE IMBALANCE 26 0.0022
639 JOINT RANGE OF MOTION DECREASED 30 0.0022
640 RENAL DISORDER 104 0.0022
641 CIRCULATORY COLLAPSE 38 0.0022
642 HEART RATE DECREASED 78 0.0022
643 NAUSEA 1755 0.0022
644 PRODUCT STORAGE ERROR 194 0.0022
645 MITRAL VALVE INCOMPETENCE 25 0.0022
646 PETECHIAE 23 0.0022
647 DEEP VEIN THROMBOSIS 143 0.0022
648 GASTROENTERITIS 32 0.0022
649 ARTHRITIS 172 0.0022
650 DRUG ADMINISTRATION ERROR 67 0.0022
651 NIGHTMARE 75 0.0022
652 BLOOD PRESSURE FLUCTUATION 52 0.0022
653 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 113 0.0022
654 LUNG DISORDER 106 0.0022
655 DRUG LEVEL DECREASED 22 0.0022
656 OEDEMA 117 0.0022
657 JAUNDICE 58 0.0022
658 POST PROCEDURAL HAEMORRHAGE 25 0.0021
659 CARPAL TUNNEL SYNDROME 30 0.0021
660 FEBRILE NEUTROPENIA 142 0.0021
661 BLOOD TEST ABNORMAL 30 0.0021
662 THIRST 38 0.0021
663 PERICARDIAL EFFUSION 49 0.0021
664 WEIGHT FLUCTUATION 22 0.0021
665 MUSCLE TIGHTNESS 34 0.0021
666 BLOOD GLUCOSE FLUCTUATION 23 0.0021
667 DISCOMFORT 128 0.0021
668 HYPERLIPIDAEMIA 25 0.0021
669 DEVICE MALFUNCTION 147 0.0021
670 DENTAL CARIES 23 0.0021
671 PANCREATIC CARCINOMA 60 0.0021
672 THYROID DISORDER 32 0.0021
673 TOOTH DISORDER 46 0.0021
674 BLOOD POTASSIUM DECREASED 62 0.0021
675 DYSPNOEA 1167 0.0021
676 SKIN REACTION 29 0.0021
677 HYPOKALAEMIA 95 0.0021
678 LEUKOCYTOSIS 37 0.0020
679 PALPITATIONS 239 0.0020
680 THINKING ABNORMAL 38 0.0020
681 BACTERIAL INFECTION 38 0.0020
682 HYPOTHYROIDISM 65 0.0020
683 HEPATOMEGALY 20 0.0020
684 SMALL INTESTINAL OBSTRUCTION 25 0.0020
685 CARDIOMYOPATHY 30 0.0020
686 DRUG PRESCRIBING ERROR 39 0.0020
687 SPINAL OPERATION 25 0.0020
688 MOVEMENT DISORDER 65 0.0020
689 MACULAR DEGENERATION 24 0.0020
690 ASPIRATION 22 0.0020
691 GASTRIC ULCER 38 0.0020
692 HEART RATE INCREASED 198 0.0020
693 MUSCULOSKELETAL DISORDER 38 0.0020
694 INJECTION SITE RASH 61 0.0020
695 THERAPY PARTIAL RESPONDER 31 0.0020
696 INFLUENZA 221 0.0020
697 RASH MACULO-PAPULAR 44 0.0020
698 SARS-COV-2 TEST POSITIVE 26 0.0020
699 PROCEDURAL PAIN 54 0.0019
700 INFLUENZA LIKE ILLNESS 160 0.0019
701 ARTHROPATHY 108 0.0019
702 TENDONITIS 30 0.0019
703 PYREXIA 669 0.0019
704 EPILEPSY 59 0.0019
705 ASPARTATE AMINOTRANSFERASE INCREASED 102 0.0019
706 RASH MACULAR 67 0.0019
707 IRRITABLE BOWEL SYNDROME 41 0.0019
708 GASTRITIS 50 0.0019
709 WOUND 53 0.0019
710 PANIC ATTACK 69 0.0019
711 VIRAL INFECTION 63 0.0019
712 BLINDNESS 77 0.0019
713 FLATULENCE 107 0.0019
714 FULL BLOOD COUNT DECREASED 38 0.0019
715 WHITE BLOOD CELL COUNT INCREASED 72 0.0019
716 MYELODYSPLASTIC SYNDROME 27 0.0019
717 HYPERTHYROIDISM 27 0.0019
718 HYPERCALCAEMIA 23 0.0019
719 ANOREXIA 24 0.0019
720 MENTAL DISORDER 81 0.0019
721 HYPOKINESIA 27 0.0019
722 HYPOAESTHESIA ORAL 28 0.0019
723 RENAL FAILURE 246 0.0019
724 BLOOD UREA INCREASED 31 0.0018
725 MYELOSUPPRESSION 66 0.0018
726 RETCHING 39 0.0018
727 DISORIENTATION 72 0.0018
728 DRUG-INDUCED LIVER INJURY 57 0.0018
729 BLOOD BILIRUBIN INCREASED 49 0.0018
730 VOMITING 852 0.0018
731 HEAD DISCOMFORT 32 0.0018
732 RESPIRATORY TRACT INFECTION 47 0.0018
733 WHITE BLOOD CELL COUNT DECREASED 195 0.0018
734 SKIN DISORDER 60 0.0018
735 AGGRESSION 90 0.0018
736 GASTROINTESTINAL DISORDER 161 0.0018
737 CARDIAC ARREST 148 0.0018
738 ALANINE AMINOTRANSFERASE INCREASED 110 0.0018
739 NEUTROPHIL COUNT DECREASED 73 0.0018
740 FACE OEDEMA 30 0.0018
741 PULMONARY FIBROSIS 34 0.0018
742 TACHYCARDIA 157 0.0018
743 SEASONAL ALLERGY 25 0.0018
744 JOINT SWELLING 213 0.0018
745 PNEUMONITIS 48 0.0018
746 CHOLECYSTITIS 21 0.0018
747 LABORATORY TEST ABNORMAL 52 0.0018
748 ACUTE HEPATIC FAILURE 24 0.0018
749 SPEECH DISORDER 92 0.0018
750 RESPIRATORY FAILURE 128 0.0018
751 DRUG INEFFECTIVE 2307 0.0017
752 HEPATIC CANCER 42 0.0017
753 SWELLING 163 0.0017
754 RASH PAPULAR 39 0.0017
755 BURNING SENSATION 122 0.0017
756 ABNORMAL DREAMS 48 0.0017
757 GASTRIC CANCER 44 0.0017
758 DYSGEUSIA 129 0.0017
759 LIVER DISORDER 77 0.0017
760 BASAL CELL CARCINOMA 27 0.0017
761 BRONCHITIS 128 0.0017
762 SLEEP APNOEA SYNDROME 33 0.0017
763 STAPHYLOCOCCAL INFECTION 57 0.0017
764 MELAENA 38 0.0017
765 INTENTIONAL PRODUCT MISUSE 151 0.0017
766 ACUTE RESPIRATORY FAILURE 33 0.0017
767 BLADDER CANCER 101 0.0017
768 DRY MOUTH 139 0.0017
769 EPISTAXIS 128 0.0017
770 INFLAMMATION 88 0.0017
771 ABDOMINAL PAIN UPPER 351 0.0017
772 MUSCLE TWITCHING 39 0.0017
773 ILEUS 21 0.0017
774 SECRETION DISCHARGE 21 0.0017
775 HYPERGLYCAEMIA 61 0.0017
776 DRUG RESISTANCE 43 0.0017
777 DERMATITIS 35 0.0017
778 ILLNESS 171 0.0017
779 HEPATIC FAILURE 50 0.0017
780 DIARRHOEA 1070 0.0017
781 DYSPHAGIA 157 0.0017
782 COMPLICATION ASSOCIATED WITH DEVICE 24 0.0017
783 DYSPEPSIA 162 0.0016
784 VISUAL IMPAIRMENT 204 0.0016
785 EATING DISORDER 35 0.0016
786 HEPATITIS 42 0.0016
787 TOOTH LOSS 34 0.0016
788 RESPIRATORY TRACT CONGESTION 26 0.0016
789 SCAR 28 0.0016
790 SKIN DISCOLOURATION 75 0.0016
791 RHABDOMYOLYSIS 68 0.0016
792 ABDOMINAL DISCOMFORT 273 0.0016
793 DEVICE RELATED INFECTION 25 0.0016
794 DIVERTICULITIS 45 0.0016
795 PRURITUS GENERALISED 35 0.0016
796 IMPAIRED HEALING 53 0.0016
797 NEUTROPENIA 219 0.0016
798 SEIZURE 186 0.0016
799 BACK DISORDER 26 0.0016
800 INJECTION SITE PRURITUS 107 0.0016
801 PRODUCTIVE COUGH 76 0.0016
802 BLOOD PRESSURE SYSTOLIC INCREASED 31 0.0016
803 PRODUCT DOSE OMISSION IN ERROR 45 0.0016
804 CARDIO-RESPIRATORY ARREST 66 0.0016
805 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
806 DYSARTHRIA 59 0.0016
807 GLYCOSYLATED HAEMOGLOBIN INCREASED 39 0.0015
808 DIPLOPIA 40 0.0015
809 INFECTION 222 0.0015
810 RASH 668 0.0015
811 HYPOTENSION 306 0.0015
812 TYPE 2 DIABETES MELLITUS 51 0.0015
813 VENTRICULAR TACHYCARDIA 25 0.0015
814 SOMNOLENCE 302 0.0015
815 DRUG DOSE OMISSION 247 0.0015
816 BLINDNESS UNILATERAL 21 0.0015
817 PANCYTOPENIA 83 0.0015
818 LUNG INFECTION 23 0.0015
819 MENINGIOMA 23 0.0015
820 BODY TEMPERATURE INCREASED 30 0.0015
821 DRUG INTERACTION 233 0.0015
822 RASH GENERALISED 38 0.0015
823 HYPOACUSIS 63 0.0015
824 GALLBLADDER DISORDER 26 0.0015
825 GASTROOESOPHAGEAL REFLUX DISEASE 117 0.0015
826 BRADYCARDIA 77 0.0015
827 URTICARIA 242 0.0014
828 RENAL IMPAIRMENT 121 0.0014
829 ABNORMAL BEHAVIOUR 57 0.0014
830 HYPOMAGNESAEMIA 20 0.0014
831 PHOTOPHOBIA 27 0.0014
832 CHEST DISCOMFORT 147 0.0014
833 ECZEMA 75 0.0014
834 SKIN LESION 39 0.0014
835 CLOSTRIDIUM DIFFICILE INFECTION 31 0.0014
836 HYPOXIA 50 0.0014
837 BLOOD TRIGLYCERIDES INCREASED 25 0.0014
838 RESTLESSNESS 51 0.0014
839 PRURITUS 535 0.0014
840 BLOOD COUNT ABNORMAL 21 0.0014
841 FAECES DISCOLOURED 30 0.0014
842 FREQUENT BOWEL MOVEMENTS 37 0.0014
843 THROMBOCYTOPENIA 153 0.0014
844 SWELLING FACE 89 0.0014
845 HEPATIC ENZYME INCREASED 93 0.0014
846 THERAPEUTIC RESPONSE UNEXPECTED 61 0.0014
847 GAMMA-GLUTAMYLTRANSFERASE INCREASED 30 0.0014
848 HYPONATRAEMIA 76 0.0013
849 C-REACTIVE PROTEIN INCREASED 49 0.0013
850 ACUTE KIDNEY INJURY 206 0.0013
851 DRUG INTOLERANCE 130 0.0013
852 DRY SKIN 179 0.0013
853 PHOTOSENSITIVITY REACTION 22 0.0013
854 KNEE ARTHROPLASTY 28 0.0013
855 NASOPHARYNGITIS 245 0.0013
856 COUGH 372 0.0013
857 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 94 0.0013
858 PLATELET COUNT DECREASED 140 0.0013
859 RASH ERYTHEMATOUS 62 0.0013
860 BLOOD POTASSIUM INCREASED 21 0.0013
861 NERVOUS SYSTEM DISORDER 40 0.0013
862 ACCIDENTAL EXPOSURE TO PRODUCT 132 0.0013
863 HALLUCINATION, VISUAL 27 0.0013
864 UPPER RESPIRATORY TRACT INFECTION 59 0.0013
865 CONVULSION 73 0.0013
866 AGITATION 93 0.0013
867 OXYGEN SATURATION DECREASED 71 0.0013
868 PREMATURE BABY 38 0.0013
869 HALLUCINATION 95 0.0013
870 FEELING JITTERY 24 0.0013
871 NEUROTOXICITY 22 0.0013
872 RHINORRHOEA 81 0.0013
873 CHOLESTASIS 24 0.0012
874 RENAL FAILURE ACUTE 53 0.0012
875 OSTEONECROSIS 41 0.0012
876 UPPER GASTROINTESTINAL HAEMORRHAGE 21 0.0012
877 PULMONARY HYPERTENSION 26 0.0012
878 SUICIDE ATTEMPT 75 0.0012
879 FUNGAL INFECTION 41 0.0012
880 BLOOD CREATININE INCREASED 80 0.0012
881 LACRIMATION INCREASED 37 0.0012
882 MENTAL STATUS CHANGES 34 0.0012
883 TREMOR 202 0.0012
884 EAR INFECTION 32 0.0012
885 LEUKOPENIA 60 0.0012
886 OROPHARYNGEAL PAIN 111 0.0012
887 HYPERKALAEMIA 42 0.0012
888 BLOOD GLUCOSE INCREASED 225 0.0012
889 DRUG ERUPTION 21 0.0012
890 FLUSHING 120 0.0012
891 DYSPHONIA 69 0.0012
892 UNRESPONSIVE TO STIMULI 30 0.0012
893 DRUG EFFECT INCOMPLETE 42 0.0012
894 TINNITUS 53 0.0012
895 TREATMENT NONCOMPLIANCE 63 0.0012
896 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 21 0.0011
897 VISUAL ACUITY REDUCED 38 0.0011
898 LOWER RESPIRATORY TRACT INFECTION 52 0.0011
899 ERYTHEMA 235 0.0011
900 LIP SWELLING 38 0.0011
901 MOUTH ULCERATION 24 0.0011
902 ERUCTATION 22 0.0011
903 CONDITION AGGRAVATED 344 0.0011
904 SEPTIC SHOCK 49 0.0011
905 ADVERSE EVENT 103 0.0011
906 CARDIOVASCULAR DISORDER 28 0.0011
907 PREGNANCY 22 0.0011
908 PRODUCT DOSE OMISSION 71 0.0011
909 COLITIS 41 0.0011
910 PANCREATITIS 57 0.0011
911 CHOKING 21 0.0011
912 HYPOGLYCAEMIA 52 0.0011
913 ILL-DEFINED DISORDER 65 0.0011
914 DRUG ABUSE 89 0.0011
915 DISABILITY 21 0.0011
916 DEPRESSED LEVEL OF CONSCIOUSNESS 42 0.0011
917 PRODUCT USE ISSUE 198 0.0011
918 INTERNATIONAL NORMALISED RATIO INCREASED 30 0.0011
919 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 49 0.0010
920 EYE SWELLING 39 0.0010
921 SINUSITIS 107 0.0010
922 THROAT TIGHTNESS 28 0.0010
923 BONE MARROW FAILURE 21 0.0010
924 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29 0.0010
925 GASTRIC DISORDER 35 0.0010
926 BLISTER 57 0.0010
927 RESPIRATORY DISTRESS 28 0.0010
928 GASTROINTESTINAL HAEMORRHAGE 84 0.0010
929 NASAL CONGESTION 59 0.0010
930 FEAR 27 0.0010
931 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 55 0.0010
932 PLASMA CELL MYELOMA 39 0.0010
933 HYPERSENSITIVITY 185 0.0010
934 FOETAL EXPOSURE DURING PREGNANCY 80 0.0010
935 ENCEPHALOPATHY 24 0.0010
936 EYE DISORDER 32 0.0010
937 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
938 HAEMOPTYSIS 27 0.0010
939 PRODUCT PRESCRIBING ISSUE 21 0.0010
940 WRONG TECHNIQUE IN DRUG USAGE PROCESS 35 0.0010
941 PSYCHOTIC DISORDER 28 0.0009
942 PRODUCT DOSE OMISSION ISSUE 278 0.0009
943 RESPIRATORY ARREST 26 0.0009
944 SNEEZING 21 0.0009
945 CHRONIC KIDNEY DISEASE 71 0.0009
946 THERAPY NON-RESPONDER 42 0.0009
947 INJURY 65 0.0009
948 PRODUCT USE IN UNAPPROVED INDICATION 224 0.0009
949 LIVER FUNCTION TEST ABNORMAL 26 0.0009
950 ORAL PAIN 20 0.0009
951 WHEEZING 52 0.0009
952 DRUG EFFECT DECREASED 47 0.0009
953 DYSKINESIA 35 0.0009
954 INFUSION RELATED REACTION 56 0.0008
955 ANAPHYLACTIC REACTION 46 0.0008
956 THERAPEUTIC PRODUCT EFFECT DECREASED 37 0.0008
957 EMOTIONAL DISTRESS 100 0.0008
958 DRY EYE 41 0.0008
959 OESOPHAGEAL CARCINOMA 24 0.0008
960 SWOLLEN TONGUE 25 0.0008
961 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
962 BLOOD GLUCOSE DECREASED 38 0.0008
963 ANAPHYLACTIC SHOCK 20 0.0008
964 STOMATITIS 47 0.0008
965 DISEASE RECURRENCE 36 0.0008
966 COMA 36 0.0008
967 DRUG DEPENDENCE 118 0.0007
968 EYE PAIN 41 0.0007
969 THERAPEUTIC RESPONSE SHORTENED 24 0.0007
970 SKIN EXFOLIATION 59 0.0007
971 BREAST CANCER 63 0.0007
972 ASTHMA 76 0.0007
973 SYSTEMIC LUPUS ERYTHEMATOSUS 22 0.0006
974 DRUG EXPOSURE DURING PREGNANCY 21 0.0006
975 PSORIATIC ARTHROPATHY 25 0.0006
976 THERAPEUTIC RESPONSE DECREASED 33 0.0005
977 ANGIOEDEMA 24 0.0005
978 RENAL CANCER 25 0.0005
979 THROAT IRRITATION 23 0.0005
980 OCULAR HYPERAEMIA 24 0.0005
981 MATERNAL EXPOSURE DURING PREGNANCY 43 0.0005
982 TOXICITY TO VARIOUS AGENTS 78 0.0005
983 NO ADVERSE EVENT 81 0.0004
984 TREATMENT FAILURE 35 0.0004
985 SKIN BURNING SENSATION 28 0.0004
986 EYE IRRITATION 22 0.0004
987 RHEUMATOID ARTHRITIS 42 0.0004
988 PSORIASIS 46 0.0004
989 COMPLETED SUICIDE 29 0.0003
990 OVERDOSE 72 0.0003